Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 112
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Abekawa, Tomohiro 2016. Neuropathology of Drug Addictions and Substance Misuse.

    Bogale, Tegegne Engidawork, Epherm and Yisma, Engida 2016. Subchronic oral administration of crude khat extract (Catha edulis forsk) induces schizophernic-like symptoms in mice. BMC Complementary and Alternative Medicine, Vol. 16, Issue. 1,

    Farnia, Vahid and Golshani, Senobar 2016. Neuropathology of Drug Addictions and Substance Misuse.

    McKetin, Rebecca Gardner, Jonathon Baker, Amanda L. Dawe, Sharon Ali, Robert Voce, Alexandra Leach, Liana S. and Lubman, Dan I. 2016. Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users. Psychiatry Research, Vol. 238, p. 166.

    McKetin, Rebecca Dawe, Sharon Burns, Richard A. Hides, Leanne Kavanagh, David J. Teesson, Maree McD. Young, Ross Voce, Alexandra and Saunders, John B. 2016. The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug and Alcohol Dependence, Vol. 161, p. 104.

    Okada, Naohiro Takahashi, Katsuyoshi Nishimura, Yukika Koike, Shinsuke Ishii-Takahashi, Ayaka Sakakibara, Eisuke Satomura, Yoshihiro Kinoshita, Akihide Takizawa, Ryu Kawasaki, Shingo Nakakita, Mayumi Ohtani, Toshiyuki Okazaki, Yuji and Kasai, Kiyoto 2016. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study. Addiction Biology, Vol. 21, Issue. 2, p. 489.

    Park, Taryn M. and Haning, William F. 2016. Stimulant Use Disorders. Child and Adolescent Psychiatric Clinics of North America, Vol. 25, Issue. 3, p. 461.

    Tabernik, Holly E. and Vitacco, Michael J. 2016. Psychosis and Substance Use: Implications for Conditional Release Readiness Evaluations. Behavioral Sciences & the Law, Vol. 34, Issue. 2-3, p. 295.

    Weibell, Melissa A. ten Velden Hegelstad, Wenche and Johannessen, Jan Olav 2016. Neuropathology of Drug Addictions and Substance Misuse.

    Willi, Taylor S. Honer, William G. Thornton, Allen E. Gicas, Kristina Procyshyn, Ric M. Vila-Rodriguez, Fidel Panenka, William J. Aleksic, Ana Leonova, Olga Jones, Andrea A. MacEwan, G. William and Barr, Alasdair M. 2016. Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence. Psychiatry Research, Vol. 240, p. 336.

    Bousman, Chad A. McKetin, Rebecca Burns, Richard Woods, Steven Paul Morgan, Erin E. Atkinson, J. Hampton Everall, Ian P. and Grant, Igor 2015. Typologies of positive psychotic symptoms in methamphetamine dependence. The American Journal on Addictions, Vol. 24, Issue. 2, p. 94.

    Chen, Yi-Chih Wang, Liang-Jen Lin, Shih-Ku and Chen, Chih-Ken 2015. Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use. Substance Use & Misuse, Vol. 50, Issue. 14, p. 1778.

    Chen, Chih-Ken Lin, Shih-Ku Chen, Yi-Chih Huang, Ming-Chy Chen, Tzu-Ting Ree, Shao Chun and Wang, Liang-Jen 2015. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users. Drug and Alcohol Dependence, Vol. 148, p. 158.

    Fassbender, Catherine Lesh, Tyler A. Ursu, Stefan and Salo, Ruth 2015. Reaction Time Variability and Related Brain Activity in Methamphetamine Psychosis. Biological Psychiatry, Vol. 77, Issue. 5, p. 465.

    Harro, Jaanus 2015. The Neuropsychiatric Complications of Stimulant Abuse.

    Hides, Leanne Dawe, Sharon McKetin, Rebecca Kavanagh, David J. Young, Ross McD. Teesson, Maree and Saunders, John B. 2015. Primary and substance-induced psychotic disorders in methamphetamine users. Psychiatry Research, Vol. 226, Issue. 1, p. 91.

    Lipinska, Gosia Timol, Ridwana and Thomas, Kevin G.F. 2015. The implications of sleep disruption for cognitive and affective processing in methamphetamine abuse. Medical Hypotheses, Vol. 85, Issue. 6, p. 914.

    Mason, O. J. 2015. The Assessment of Schizotypy and Its Clinical Relevance. Schizophrenia Bulletin, Vol. 41, Issue. suppl 2, p. S374.

    Rognli, Eline Borger Medhus, Sigrid Elisabet and Bramness, Jørgen G. 2015. Amfetaminutløst psykose eller schizofreni?. Tidsskrift for Den norske legeforening, Vol. 135, Issue. 3, p. 249.

    Rognli, Eline Borger and Bramness, Jørgen G. 2015. Understanding the Relationship Between Amphetamines and Psychosis. Current Addiction Reports, Vol. 2, Issue. 4, p. 285.


Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis

  • C.-K. CHEN (a1), S.-K. LIN (a1), P. C. SHAM (a1), D. BALL (a1), E.-W. LOH (a1), C.-C. HSIAO (a1), Y.-L. CHIANG (a1), S.-C. REE (a1), C.-H. LEE (a1) and R. M. MURRAY (a1)
  • DOI:
  • Published online: 01 November 2003

Background. The long-term use of methamphetamine (MAMP) can result in psychosis but it is not clear why some individuals develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We set out to characterize MAMP users and to examine the relationship of pre-morbid personality, pre-morbid social function and other psychiatric disorders to MAMP psychosis.

Method. Four hundred and forty-five amphetamine users were recruited from a psychiatric hospital and a detention centre in Taipei, and were assessed with the Diagnostic Interview for Genetic Studies (DIGS). Their parents were interviewed with the Premorbid Schizoid and Schizotypal Traits (PSST) and the Premorbid Social Adjustment (PSA) schedules. Pre-morbid characteristics and psychiatric co-morbidity were compared between the MAMP users with a lifetime diagnosis of MAMP psychosis and those without.

Results. The MAMP users with psychosis presented a clinical picture which mimicked the positive symptoms of schizophrenia: 85% had auditory hallucinations; 71% persecutory delusions; 63% delusions of reference. Compared with their non-psychotic counterparts, these MAMP users were younger at first MAMP use, used larger amounts of MAMP, had a significantly higher mean PSST score, and higher rates of major depressive disorder, alcohol dependence and antisocial personality disorder.

Conclusions. Earlier and larger use of MAMP was associated with increased risk of psychosis. Our data are also compatible with the view that pre-morbid schizoid/schizotypal personality predisposes MAMP users to develop psychosis, and that the greater the personality vulnerability, the longer the psychosis will persist.

Corresponding author
Professor Robin M. Murray, Division of Psychological Medicine, Institute of Psychiatry, De Crespigny Park, London SE5 8AF.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *